Skip to main content
SpringerLink
Log in

Does the pharmacologic or biologic modulation of apoptosis impact disease severity?

  • Book Review
  • Published:
Apoptosis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. R. E. Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology, National Academy of Sciences of Ukraine, Ukraine

    A. Philchenkov

  2. R. E. Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology, 45, Vasilkovkaya Str., Kyiv, 03022, Ukraine

    A. Philchenkov

Authors
  1. A. Philchenkov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Philchenkov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Philchenkov, A. Does the pharmacologic or biologic modulation of apoptosis impact disease severity?. Apoptosis 11, 287–288 (2006). https://doi.org/10.1007/s10495-006-3755-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-006-3755-9

Search

Navigation